Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
45,176,306
-
Shares change
-
-115,205
-
Total reported value, excl. options
-
$3,933,867,577
-
Value change
-
-$43,842,015
-
Put/Call ratio
-
122%
-
Number of buys
-
132
-
Number of sells
-
-79
-
Price
-
$87.01
Significant Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q3 2021
273 filings reported holding BEAM - Beam Therapeutics Inc. - COMMON STOCK as of Q3 2021.
Beam Therapeutics Inc. - COMMON STOCK (BEAM) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45,176,306 shares
of 101,224,395 outstanding shares and own 44.63% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (6,841,722 shares), VANGUARD GROUP INC (4,516,700 shares), FMR LLC (3,924,166 shares), BlackRock Inc. (3,519,975 shares), Temasek Holdings (Private) Ltd (3,457,385 shares), MWG Management Ltd. (2,362,635 shares), Redmile Group, LLC (1,975,006 shares), FARALLON CAPITAL MANAGEMENT LLC (1,717,590 shares), HHLR ADVISORS, LTD. (1,448,161 shares), and STATE STREET CORP (1,401,720 shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.